OBSOLETE: Primary T cell immunodeficiency

Primary T cell immunodeficiency (Orphanet code 2284) is an obsolete disease classification that was previously used to describe a group of inherited immune system disorders characterized by deficient or dysfunctional T lymphocytes (T cells). T cells are critical components of the adaptive immune system responsible for cell-mediated immunity, and their deficiency leads to increased susceptibility to infections, particularly opportunistic infections caused by viruses, fungi, and intracellular bacteria. Affected individuals typically present with recurrent, severe, or unusual infections beginning in infancy or early childhood, failure to thrive, chronic diarrhea, and skin manifestations. The immune system is the primary body system affected, though secondary complications can involve the lungs, gastrointestinal tract, skin, and other organs due to chronic or recurrent infections. This term has been rendered obsolete in current nosology because the conditions it encompassed have been reclassified into more specific diagnostic entities as the molecular and genetic basis of these disorders has been elucidated. These include severe combined immunodeficiencies (SCID), combined immunodeficiencies, and other well-defined T cell deficiency syndromes, each with distinct genetic etiologies and clinical features. Patients previously classified under this umbrella term would now be diagnosed with specific conditions such as SCID variants, DiGeorge syndrome, or other defined primary immunodeficiencies. Treatment approaches for T cell immunodeficiencies generally include infection prophylaxis with antimicrobials, immunoglobulin replacement therapy, and in severe cases, hematopoietic stem cell transplantation (bone marrow transplant), which can be curative. Gene therapy has also emerged as a treatment option for select forms of T cell immunodeficiency.

Common questions about OBSOLETE: Primary T cell immunodeficiency